P3 Research to move in with AusTrials

P3 Research to move in with AusTrials
Genesis Capital's Dr Michael Caristo. (Image: Genesis Capital)
Staff reporters
Healthcare private equity investor Genesis Capital has added clinical trials company AusTrials to its portfolio, with plans to wrap it up into a trans-Tasman offering with New Zealand's P3 Research.The Sydney firm bought a 90% stake in P3 in December and indicated investing $30 million to back P3's growth trials.P3 is the largest player in the NZ market for large- and small-scale early trial work, alongside Pacific Clinical Research Network and NZ Clinical Research.A 2020 report by the NZ Institute of Economic Research estimated clinica...